Drug profile · INN
meclocycline sulfosalicylate
MECLAN
meclocycline sulfosalicylate (MECLAN) is a bacterial 70s ribosome inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — meclocycline sulfosalicylate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
meclocycline sulfosalicylate (MECLAN) is a bacterial 70s ribosome inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is meclocycline sulfosalicylate?
meclocycline sulfosalicylate (MECLAN) is a bacterial 70s ribosome inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for meclocycline sulfosalicylate?
MECLAN is a marketed brand name for meclocycline sulfosalicylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of meclocycline sulfosalicylate?
meclocycline sulfosalicylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.